- Home
- CODX vs CXAI Comparison
CODX vs CXAI Comparison
Compare CODX & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- CXAI
- Stock Information
- Founded
- CODX 2013
- CXAI N/A
- Country
- CODX United States
- CXAI United States
- Employees
- CODX N/A
- CXAI N/A
- Industry
- CODX Medical/Dental Instruments
- CXAI EDP Services
- Sector
- CODX Health Care
- CXAI Technology
- Exchange
- CODX Nasdaq
- CXAI Nasdaq
- Market Cap
- CODX 22.0M
- CXAI 22.4M
- IPO Year
- CODX 2017
- CXAI N/A
- Fundamental
- Price
- CODX $0.35
- CXAI $1.19
- Analyst Decision
- CODX Hold
- CXAI
- Analyst Count
- CODX 1
- CXAI 0
- Target Price
- CODX $1.00
- CXAI N/A
- AVG Volume (30 Days)
- CODX 163.5K
- CXAI 6.2M
- Earning Date
- CODX 05-08-2025
- CXAI 04-07-2025
- Dividend Yield
- CODX N/A
- CXAI N/A
- EPS Growth
- CODX N/A
- CXAI N/A
- EPS
- CODX N/A
- CXAI N/A
- Revenue
- CODX $3,915,160.00
- CXAI $7,142,000.00
- Revenue This Year
- CODX N/A
- CXAI $114.23
- Revenue Next Year
- CODX N/A
- CXAI N/A
- P/E Ratio
- CODX N/A
- CXAI N/A
- Revenue Growth
- CODX N/A
- CXAI N/A
- 52 Week Low
- CODX $0.28
- CXAI $0.76
- 52 Week High
- CODX $2.23
- CXAI $4.06
- Technical
- Relative Strength Index (RSI)
- CODX 42.44
- CXAI 56.25
- Support Level
- CODX $0.32
- CXAI $1.03
- Resistance Level
- CODX $0.38
- CXAI $1.12
- Average True Range (ATR)
- CODX 0.05
- CXAI 0.13
- MACD
- CODX 0.01
- CXAI 0.02
- Stochastic Oscillator
- CODX 60.87
- CXAI 71.43
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.